Skip to content

AxoGen

US · AXGN #2714 by market cap Listed 1970
55.75 -0.60 -1.06%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Rating change
    A Quick Look at Today's Ratings for AxoGen(AXGN.US), With a Forecast Between $48 to $55
    Market Newswire · 2026/4/30
  • Rating change
    Jefferies Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $50
    Market Newswire · 2026/7/6
  • Rating change
    CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $50
    Market Newswire · 2026/5/4
  • Rating change
    Raymond James Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $53
    Market Newswire · 2026/9/25
  • Rating change
    Leerink Partners Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $52
    Market Newswire · 2026/10/13
  • Rating change
    Truist Financial Initiates AxoGen(AXGN.US) With Buy Rating, Announces Target Price $60
    Market Newswire · 2026/8/26
  • Barclays Maintains AxoGen(AXGN.US) With Buy Rating, Cuts Target Price to $50
    Market Newswire · 2026/10/23
  • Truist Financial Maintains AxoGen(AXGN.US) With Buy Rating, Announces Target Price $53
    Market Newswire · 2026/10/1
  • Rating change
    A Quick Look at Today's Ratings for AxoGen(AXGN.US), With a Forecast Between $53 to $55
    Market Newswire · 2026/7/31
  • Rating change
    CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $55
    Market Newswire · 2026/10/5
  • Rating change
    Barclays Initiates AxoGen(AXGN.US) With Buy Rating, Announces Target Price $55
    Market Newswire · 2026/10/8
  • Rating change
    Truist Financial Maintains AxoGen(AXGN.US) With Buy Rating
    Market Newswire · 2026/9/29
  • Rating change
    Wells Fargo Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $48
    Market Newswire · 2026/10/3
  • CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $60
    Market Newswire · 2026/11/12
  • Rating change
    Jefferies Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $55
    Market Newswire · 2026/9/29
  • Rating change
    BofA Securities Initiates AxoGen(AXGN.US) With Buy Rating, Announces Target Price $52
    Market Newswire · 2026/10/12
  • Rating change
    Lake Street Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $55
    Market Newswire · 2026/10/5
  • A Quick Look at Today's Ratings for AxoGen(AXGN.US), With a Forecast Between $56 to $65
    Market Newswire · 2026/10/30
  • Lake Street Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $60
    Market Newswire · 2026/11/10
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), AxoGen (AXGN) and Biohaven Ltd. (BHVN)
    TipRanks · 2026/9/30
  • Rating change
    A Quick Look at Today's Ratings for AxoGen(AXGN.US), With a Forecast Between $50 to $50
    Market Newswire · 2026/4/29
  • Earnings Flash (AXGN) Axogen, Inc. Posts Q3 Adjusted EPS $0.21 per Share, Vs. FactSet Est of $0.13
    MT Newswires · 2026/10/28
  • Rating change
    CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $45
    Market Newswire · 2026/4/24
  • Rating change
    Lake Street Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $50
    Market Newswire · 2026/4/23
  • Rating change
    Lake Street Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $50
    Market Newswire · 2026/4/27

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

AxoGen discussion 0 comments

Add a comment